Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Innate Pharma SA

2.14
-0.1600-6.96%
Post-market: 2.00-0.1400-6.54%17:07 EST
Volume:206.18K
Turnover:418.73K
Market Cap:197.28M
PE:-3.32
High:2.17
Open:2.01
Low:1.98
Close:2.30
52wk High:3.51
52wk Low:1.29
Shares:92.19M
Float Shares:59.22M
Volume Ratio:0.10
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6440
EPS(LYR):-0.6319
ROE:-271.37%
ROA:-25.92%
PB:33.10
PE(LYR):-3.39

Loading ...

OverviewCompanyNewsFilings

Innate Pharma Receives US FDA Clearance to Begin Phase 3 Trial of Potential Skin Cancer Therapy

MT Newswires Live
·
Nov 10

Innate Pharma Sa : H.c. Wainwright Raises to Buy From Neutral

THOMSON REUTERS
·
Oct 29

Innate Pharma initiated with a Buy at Lucid Capital

TIPRANKS
·
Oct 23

Goldman Sachs Sticks to Their Hold Rating for Innate Pharma SA (IPHYF)

TIPRANKS
·
Oct 08

Innate Pharma Sa : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
Sep 18

Innate Pharma SA Reports First Half 2025 Financial Results

TIPRANKS
·
Sep 18

Press Release: Innate Pharma Reports First Half 2025 Business Update and Financial Results

Dow Jones
·
Sep 17

Press Release: Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update

Dow Jones
·
Sep 10

Innate Pharma Sa : Btig Initiates Coverage With Buy Rating; Target Price $8

THOMSON REUTERS
·
Jul 28

BTIG Research Initiates Coverage on Innate Pharma With Buy Rating, $8 Price Target

MT Newswires Live
·
Jul 28

Analyst Rate

Buy
Buy
50.00%
Hold
50.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Sep 17, 2025
Financial Report Announcement
May 13, 2025
Financial Report Announcement
Mar 27, 2025 Pre-Market
Financial Report Announcement
Nov 13, 2024 Pre-Market
Financial Report Announcement
Sep 12, 2024 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-3.57
Current
-6.45
Sector Average
67.87%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-3.57
Maximum
-2.78
+1 STD
-0.85
Minimum
-28.51
-1 STD
-12.05
Average
-6.45

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.